| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel
|
Gilewski, Teresa
|
|
2000
|
46 |
1 |
p. S23-S26
|
article
|
| 2 |
A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism
|
Matsuba, Y.
|
|
2000
|
46 |
1 |
p. 1-9
|
article
|
| 3 |
A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility
|
Sirotnak, F. M.
|
|
2000
|
46 |
1 |
p. 79-83
|
article
|
| 4 |
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
|
Nelson, William G.
|
|
2000
|
46 |
1 |
p. S67-S72
|
article
|
| 5 |
Cancer immunotherapy in clinical oncology
|
Knuth, Alexander
|
|
2000
|
46 |
1 |
p. S46-S51
|
article
|
| 6 |
Development of a cancer vaccine: peptides, proteins, and DNA
|
Shiku, Hiroshi
|
|
2000
|
46 |
1 |
p. S77-S82
|
article
|
| 7 |
Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
|
Murren, John R.
|
|
2000
|
46 |
1 |
p. 43-50
|
article
|
| 8 |
Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women
|
Dowsett, Mitchell
|
|
2000
|
46 |
1 |
p. 35-39
|
article
|
| 9 |
Erratum: Cancer Chemother Pharmacol 45:345–349
|
,
|
|
2000
|
46 |
1 |
p. 84
|
article
|
| 10 |
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine
|
Braybrooke, Jeremy P.
|
|
2000
|
46 |
1 |
p. 27-34
|
article
|
| 11 |
Exploitation of the B cell repertoire for the identification of human tumor antigens
|
Pfreundschuh, Michael
|
|
2000
|
46 |
1 |
p. S3-S7
|
article
|
| 12 |
Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy
|
Westermann, Anneke M.
|
|
2000
|
46 |
1 |
p. 57-62
|
article
|
| 13 |
Human CD8 and CD4 T cell epitopes of epithelial cancer antigens
|
Sato, Noriyuki
|
|
2000
|
46 |
1 |
p. S86-S90
|
article
|
| 14 |
Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease
|
da Costa, Ligia
|
|
2000
|
46 |
1 |
p. S33-S36
|
article
|
| 15 |
Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats
|
Fuskevåg, Ole-Martin
|
|
2000
|
46 |
1 |
p. 69-73
|
article
|
| 16 |
Melanoma vaccines: the paradox of T cell activation without clinical response
|
Nielsen, Mai-Britt
|
|
2000
|
46 |
1 |
p. S62-S66
|
article
|
| 17 |
Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer
|
Sakamoto, Junichi
|
|
2000
|
46 |
1 |
p. S27-S32
|
article
|
| 18 |
Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours
|
Harrington, Kevin J.
|
|
2000
|
46 |
1 |
p. 10-18
|
article
|
| 19 |
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis
|
Tetef, Merry L.
|
|
2000
|
46 |
1 |
p. 19-26
|
article
|
| 20 |
Pharmacokinetics of 2-chloro-2′-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
|
Sonderegger, Theodor
|
|
2000
|
46 |
1 |
p. 40-42
|
article
|
| 21 |
Preface
|
Saito, Hidehiko
|
|
2000
|
46 |
1 |
p. S1
|
article
|
| 22 |
Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID) – a phase II study
|
Taylor, Penelope
|
|
2000
|
46 |
1 |
p. 63-68
|
article
|
| 23 |
Problems in the development of target-based drugs
|
Saijo, Nagahiro
|
|
2000
|
46 |
1 |
p. S43-S45
|
article
|
| 24 |
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells
|
Tani, Kenzaburo
|
|
2000
|
46 |
1 |
p. S73-S76
|
article
|
| 25 |
Recombinant antibodies against ganglioside expressed on tumor cells
|
Hanai, Nobuo
|
|
2000
|
46 |
1 |
p. S13-S17
|
article
|
| 26 |
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer
|
Chester, Kerry A.
|
|
2000
|
46 |
1 |
p. S8-S12
|
article
|
| 27 |
Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats
|
Yoshisue, Kunihiro
|
|
2000
|
46 |
1 |
p. 51-56
|
article
|
| 28 |
Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo
|
Caffrey, Paula B.
|
|
2000
|
46 |
1 |
p. 74-78
|
article
|
| 29 |
SEREX analysis of gastric cancer antigens
|
Obata, Yuichi
|
|
2000
|
46 |
1 |
p. S37-S42
|
article
|
| 30 |
Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates
|
Sievers, Eric L.
|
|
2000
|
46 |
1 |
p. S18-S22
|
article
|
| 31 |
The critical role of Th1-dominant immunity in tumor immunology
|
Nishimura, Takashi
|
|
2000
|
46 |
1 |
p. S52-S61
|
article
|
| 32 |
Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients
|
Cerundolo, Vincenzo
|
|
2000
|
46 |
1 |
p. S83-S85
|
article
|
Journal description